Isbn: 9780309120883 - breakthrough business models: drug development for rare and neglected diseases and individualized therapies: workshop summary (clinical trial data sharing) (11 resultados)
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (Clinical Trial Data Sharing)
Institute Of Medicine; Board On Health Sciences Policy; Forum On Drug Discovery, Development, And Translation; Giffin, Robert; Robinson, Sally; Wizemann, Theresa
- Tapa blanda
Librería: -OnTimeBooks-, Phoenix, AZ, Estados Unidos de America-OnTimeBooks-
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Aceptable
EUR 44,35
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponible
Condición: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail.…
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute of Medicine (U. S.) (COR)
- Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 54,20
Envío por EUR 2,35Se envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponible
Condición: As New. Unread book in perfect condition.
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute of Medicine (U. S.) (COR)
- Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 59,99
Envío por EUR 2,35Se envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponible
Condición: New.
- Tapa blanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 62,41
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Wizeman, Theresa; Robinson, Sally; Giffin, Robert; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute
- Tapa blanda
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 62,87
Envío por EUR 9,50Se envía de Irlanda a Estados Unidos de AmericaCantidad disponible: 10 disponibles
Condición: New. Num Pages: 150 pages. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 10. Weight in Grams: 249. . 2009. New. paperback. . . . .
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute of Medicine (U. S.) (COR)
- Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino UnidoGreatBookPricesUK
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 59,87
Envío por EUR 17,65Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponible
Condición: As New. Unread book in perfect condition.
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M./ Robinson, Sally/ Giffin, Robert/ Institute of Medicine (U. S.)
- Tapa blanda
Librería: Revaluation Books, Exeter, Reino UnidoRevaluation Books
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 70,96
Envío por EUR 11,77Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: Brand New. 150 pages. 8.80x6.00x0.40 inches. In Stock.
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute of Medicine (U. S.) (COR)
- Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino UnidoGreatBookPricesUK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 69,58
Envío por EUR 17,65Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponible
Condición: New.
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Wizeman, Theresa; Robinson, Sally; Giffin, Robert; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute
- Tapa blanda
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de AmericaKennys Bookstore
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 81,03
Envío por EUR 9,33Se envía dentro de Estados Unidos de AmericaCantidad disponible: 10 disponibles
Condición: New. Num Pages: 150 pages. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 10. Weight in Grams: 249. . 2009. New. paperback. . . . . Books ship from the US and Ireland.
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Institute of Medicine|Board on Health Sciences Policy|Forum on Drug Discovery Development and
- Tapa blanda
Librería: moluna, Greven, Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 53,75
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponible
Condición: New.
- Tapa blanda
Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 77,88
Envío por EUR 32,88Se envía de Australia a Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…
